These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19777373)

  • 21. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Wallenstein G
    J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis.
    Bansback N; Marra C; Tsuchiya A; Anis A; Guh D; Hammond T; Brazier J
    Arthritis Rheum; 2007 Aug; 57(6):963-71. PubMed ID: 17665482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD).
    Chen J; Wong CK; McGhee SM; Pang PK; Yu WC
    PLoS One; 2014; 9(11):e112389. PubMed ID: 25379673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis.
    Amjadi SS; Maranian PM; Paulus HE; Kaplan RM; Ranganath VK; Furst DE; Khanna PP; Khanna D;
    J Rheumatol; 2009 Jun; 36(6):1150-7. PubMed ID: 19369459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis.
    Tawiah AK; Al Sayah F; Ohinmaa A; Johnson JA
    Health Qual Life Outcomes; 2019 Apr; 17(1):68. PubMed ID: 30995930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohort.
    Adams R; Craig BM; Walsh CD; Veale DJ; Bresnihan B; FitzGerald O; Barry M
    Value Health; 2011; 14(6):921-7. PubMed ID: 21914514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes.
    Sayah FA; Qiu W; Xie F; Johnson JA
    Qual Life Res; 2017 Aug; 26(8):2057-2066. PubMed ID: 28364183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.
    Walters SJ; Brazier JE
    Qual Life Res; 2005 Aug; 14(6):1523-32. PubMed ID: 16110932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D.
    Bjerk M; Brovold T; Davis JC; Bergland A
    Qual Life Res; 2019 Dec; 28(12):3187-3195. PubMed ID: 31364036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C; Rat AC; Guillemin F; Flipo RM; Fardellone P; Bourgeois P; Fautrel B
    J Rheumatol; 2011 Aug; 38(8):1576-84. PubMed ID: 21532054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA; Huibers MJ; Theunissen KA; de Graaf LE; Widdershoven GA; Evers SM
    Value Health; 2011; 14(5):732-9. PubMed ID: 21839412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
    van Stel HF; Buskens E
    Health Qual Life Outcomes; 2006 Mar; 4():20. PubMed ID: 16563170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
    Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of EQ-5D and SF-6D utilities in mental health patients.
    Lamers LM; Bouwmans CA; van Straten A; Donker MC; Hakkaart L
    Health Econ; 2006 Nov; 15(11):1229-36. PubMed ID: 16625671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients?
    Marra CA; Rashidi AA; Guh D; Kopec JA; Abrahamowicz M; Esdaile JM; Brazier JE; Fortin PR; Anis AH
    Qual Life Res; 2005 Jun; 14(5):1333-44. PubMed ID: 16047508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D.
    Sach TH; Barton GR; Doherty M; Muir KR; Jenkinson C; Avery AJ
    Int J Obes (Lond); 2007 Jan; 31(1):189-96. PubMed ID: 16682976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.